Company Filing History:
Years Active: 2025
Title: Uzma Saeed: Innovator in ENPP1 Inhibitors
Introduction
Uzma Saeed is a prominent inventor based in Okhla, India. She has made significant contributions to the field of biochemistry, particularly in the development of compounds that target the ectonucleotide pyrophosphatase/phosphodiesterase-1 (ENPP1) enzyme. Her work is crucial for advancing treatments for conditions associated with the dysfunction of this enzyme.
Latest Patents
Uzma Saeed holds a patent for "Ectonucleotide pyrophosphatase-phosphodiesterase-1 (ENPP1) inhibitors and uses thereof." This invention discloses compounds that are useful in treating conditions linked to the over-expression of the ENPP1 gene. Specifically, the patent details a compound of formula (J) that exhibits inhibitory activity against ENPP1. The invention also outlines methods for treating conditions associated with ENPP1 dysfunction, along with pharmaceutical compositions and kits.
Career Highlights
Uzma is currently associated with 1CBio, Inc., where she continues her research and development efforts. Her innovative work has positioned her as a key figure in her field, contributing to advancements in medical treatments.
Collaborations
Uzma collaborates with notable colleagues, including Brahmam Pujala and Amantullah Ansari. These partnerships enhance her research capabilities and broaden the impact of her inventions.
Conclusion
Uzma Saeed is a trailblazer in the development of ENPP1 inhibitors, with her patent representing a significant advancement in medical science. Her contributions are vital for the treatment of conditions related to ENPP1 dysfunction, showcasing her dedication to innovation and research.